The global Lab Automation market size is expected to be worth around US$ 18.9 billion by 2030, according to a new report by Vision Research Reports.
Lab Automation Market (By Process: Continuous Flow, Discrete Processing; By Automation Type: Total Automation Systems, Modular Automation Systems; By End-use: Clinical Chemistry Analysis, Photometry & Fluorometry, Immunoassay Analysis, Electrolyte Analysis, Other end-uses) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38322
Report Insight
Report Coverage | Details |
Market Size | US$ 18.9 billion by 2030 |
Growth Rate | CAGR of 10.1% during forecast period 2021 to 2030 |
Base year | 2020 |
Historic Data | 2017 to 2020 |
Forecast Period | 2021 to 2030 |
Segments Covered | Process, automation type, end use |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | F. Hoffmann-La Roche, Qiagen N.V., PerkinElmer Inc., Thermo Fisher Scientific, Inc., Siemens Healthineers, Danaher Corporation, Agilent Technologies, Inc., Bio Tek Instruments, Inc., Eppendorf AG, Hudson Robotics, Aurora Biomed Inc., BMG LABTECH GMBH, Tecan Group Ltd., Hamilton Company. |
Report Highlights
The continuous flow segment dominated the overall market and accounted for the largest revenue share of 67.5% in 2020, owing to the high adoption of continuous flow in laboratories for providing high-quality services. In addition, continuous flow analysis is one of the well-established techniques and is also ideal when there is a need to analyze a higher number of samples for a smaller number of chemistries. Based on process, the market is segmented into continuous flow and discrete processing.
The clinical chemistry analysis segment dominated the market and held the largest revenue share of 37.0% in 2020. This high share is attributed to technological advancements, an increase in automated systems provided by market players, and growth in the usage of automated systems owing to their benefits, such as the reduced risk of contamination and elimination of human error, among other benefits. Based on end-use the market is segmented into clinical chemistry analysis, photometry and fluorometry, immunoassay analysis, and electrolyte analysis, and others.
The total automation systems segment dominated the market and accounted for the largest revenue share of 57.8% in 2020, owing to various benefits offered by these systems. The developments in this field in various life science processes have been one of the important driving factors anticipated to fuel the segment growth in the near future. Based on automation type, the market is segmented into total automation systems and modular automation systems.
Total automation systems are further segmented into steps for further process. The segment is mostly driven by the need to enable repetitive processes or technically challenging, many of the drug discovery laboratories are now adopting lab automation systems such as benchtop automation systems.
North America dominated the lab automation market and accounted for the largest revenue share of 46.4% in 2020 and is expected to maintain the position during the forecast period. The growth is attributed to the presence of a well-established healthcare infrastructure, which has led to an increase in the adoption of lab automation systems in the region. In addition, the local presence of major players and supportive reimbursement framework in this region is also boosting the penetration of novel solutions in the market.
Key Players
- Qiagen N.V.
- PerkinElmer Inc.
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio Tek Instruments, Inc.
- Eppendorf AG
- Hudson Robotics
- Aurora Biomed Inc.
- BMG LABTECH GMBH
- Tecan Group Ltd.
- Hamilton Company
- F. Hoffmann-La Roche
Market Segmentation
- Process Outlook
- Continuous Flow
- By Workflow
- Sequential Processing
- Parallel Processing
- By Components
- Consumables
- Equipment
- By Workflow
- Discrete Processing
- By Method
- Centrifugal Discrete Processing
- Random Access Discrete Processing
- By Components
- Consumables
- Equipment
- By Workflow
- Dependent Analysis
- Independent Analysis
- By Method
- Continuous Flow
- Automation Type Outlook
- Total Automation Systems
- By Steps
- Pre-analysis
- Centrifugation
- Sample Preparation
- Sample Sorting
- Transport Mechanisms
- Liquid Handling
- Sample Storage
- Sample Analysis
- Pre-analysis
- By Steps
- Modular Automation Systems
- By Steps
- Specimen Acquisition & Identification & Labelling
- Transport Mechanisms
- Sample Preparation
- Sample Loading & Aspiration
- Reagent Handling & Storage
- Sample Analysis & Measurements
- By Steps
- Total Automation Systems
- End-use Outlook
- Clinical Chemistry Analysis
- Photometry & Fluorometry
- Immunoassay Analysis
- Electrolyte Analysis
- Other end-uses
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38322
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Lab Automation Market, By Process
7.1. Lab Automation Market, by Process, 2021-2030
7.1.1. Continuous Flow
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Discrete Processing
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Lab Automation Market, By Automation Type
8.1. Lab Automation Market, by Automation Type, 2021-2030
8.1.1. Total Automation Systems
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Modular Automation Systems
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Lab Automation Market, By End-use
9.1. Lab Automation Market, by End-use, 2021-2030
9.1.1. Clinical Chemistry Analysis
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Photometry & Fluorometry
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Immunoassay Analysis
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Electrolyte Analysis
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Other end-uses
9.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Lab Automation Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Process (2016-2030)
10.1.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.1.3. Market Revenue and Forecast, by End-use (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Process (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.1.4.3. Market Revenue and Forecast, by End-use (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Process (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.1.5.3. Market Revenue and Forecast, by End-use (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Process (2016-2030)
10.2.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.2.3. Market Revenue and Forecast, by End-use (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Process (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.2.4.3. Market Revenue and Forecast, by End-use (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Process (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.2.5.3. Market Revenue and Forecast, by End-use (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Process (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.2.6.3. Market Revenue and Forecast, by End-use (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Process (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.2.7.3. Market Revenue and Forecast, by End-use (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Process (2016-2030)
10.3.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.3.3. Market Revenue and Forecast, by End-use (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Process (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.3.4.3. Market Revenue and Forecast, by End-use (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Process (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.3.5.3. Market Revenue and Forecast, by End-use (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Process (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.3.6.3. Market Revenue and Forecast, by End-use (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Process (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.3.7.3. Market Revenue and Forecast, by End-use (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Process (2016-2030)
10.4.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.4.3. Market Revenue and Forecast, by End-use (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Process (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.4.4.3. Market Revenue and Forecast, by End-use (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Process (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.4.5.3. Market Revenue and Forecast, by End-use (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Process (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.4.6.3. Market Revenue and Forecast, by End-use (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Process (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.4.7.3. Market Revenue and Forecast, by End-use (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Process (2016-2030)
10.5.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.5.3. Market Revenue and Forecast, by End-use (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Process (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.5.4.3. Market Revenue and Forecast, by End-use (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Process (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Automation Type (2016-2030)
10.5.5.3. Market Revenue and Forecast, by End-use (2016-2030)
Chapter 11. Company Profiles
11.1. Qiagen N.V.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. PerkinElmer Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Thermo Fisher Scientific, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Siemens Healthineers
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Agilent Technologies, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Bio Tek Instruments, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Eppendorf AG
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Hudson Robotics
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Aurora Biomed Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. BMG LABTECH GMBH
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Tecan Group Ltd.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Hamilton Company
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. F. Hoffmann-La Roche
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38322
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com